We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-0.77%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.55B
AUM Growth
-$472M
Cap. Flow
-$301M
Cap. Flow %
-3.99%
Top 10 Hldgs %
20.77%
Holding
863
New
59
Increased
344
Reduced
256
Closed
128

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$25.4M
2
ABBV icon
AbbVie
ABBV
+$21.9M
3
KYNB
Kyntra Bio
KYNB
+$19.2M
4
WM icon
Waste Management
WM
+$19M
5
GILD icon
Gilead Sciences
GILD
+$17.7M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$70.2M
2
ARRY
Array Biopharma Inc
ARRY
+$45.8M
3
BIIB icon
Biogen
BIIB
+$43.3M
4
META icon
Meta Platforms (Facebook)
META
+$24.8M
5
AMGN icon
Amgen
AMGN
+$21.7M

Sector Composition

Rank Sector Weight
1 Healthcare 31.81%
2 Technology 18.27%
3 Financials 10.05%
4 Consumer Discretionary 9.39%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTB icon
401
M&T Bank
MTB
$36B
$3.04M 0.04%
19,268
-375
-2% -$59K
FLS icon
402
Flowserve
FLS
$9.29B
$3.02M 0.04%
+64,665
New +$3.05M
MAR icon
403
Marriott International
MAR
$101B
$3.01M 0.04%
24,212
-5,393
-18% -$715K
TSCO icon
404
Tractor Supply
TSCO
$16.7B
$3M 0.04%
165,635
-30,600
-16% -$634K
EC icon
405
Ecopetrol
EC
$32.5B
$2.98M 0.04%
+175,000
New +$3.03M
MASI
406
DELISTED
Masimo
MASI
$2.98M 0.04%
20,000
+4,000
+25% +$608K
BCE icon
407
BCE
BCE
$19.8B
$2.96M 0.04%
61,203
-28,389
-32% -$1.33M
F icon
408
Ford
F
$58.5B
$2.95M 0.04%
321,799
+37,433
+13% +$356K
DGX icon
409
Quest Diagnostics
DGX
$25.6B
$2.93M 0.04%
27,417
+3,132
+13% +$322K
KGC icon
410
Kinross Gold
KGC
$28.6B
$2.93M 0.04%
636,855
+59,768
+10% +$277K
MLAB icon
411
Mesa Laboratories
MLAB
$540M
$2.92M 0.04%
12,273
+1,206
+11% +$279K
OMC icon
412
Omnicom Group
OMC
$23.5B
$2.91M 0.04%
37,159
+71
+0.2% +$5.64K
LVS icon
413
Las Vegas Sands
LVS
$31.6B
$2.88M 0.04%
49,814
+22,903
+85% +$1.33M
LJPC
414
DELISTED
La Jolla Pharmaceutical Company
LJPC
$2.87M 0.04%
326,300
– –
HBAN icon
415
Huntington Bancshares
HBAN
$34.7B
$2.86M 0.04%
200,670
+10,510
+6% +$144K
LRCX icon
416
Lam Research
LRCX
$365B
$2.86M 0.04%
123,890
+16,660
+16% +$350K
XLNX
417
DELISTED
Xilinx Inc
XLNX
$2.85M 0.04%
29,741
+6,833
+30% +$748K
AAL icon
418
American Airlines Group
AAL
$9.9B
$2.84M 0.04%
105,450
-139,154
-57% -$4.07M
TMUS icon
419
T-Mobile US
TMUS
$190B
$2.83M 0.04%
35,951
+12,272
+52% +$962K
GLW icon
420
Corning
GLW
$123B
$2.8M 0.04%
81,169
-74,396
-48% -$2.23M
PAYX icon
421
Paychex
PAYX
$41.1B
$2.77M 0.04%
33,441
+1,417
+4% +$118K
STT icon
422
State Street
STT
$50.7B
$2.77M 0.04%
46,768
+10,668
+30% +$592K
BN icon
423
Brookfield
BN
$103B
$2.76M 0.04%
145,580
-56,660
-28% -$1.03M
VTR icon
424
Ventas
VTR
$48.7B
$2.74M 0.04%
37,555
+8,846
+31% +$628K
APH icon
425
Amphenol
APH
$184B
$2.74M 0.04%
113,592
+7,636
+7% +$176K
15 16
17
18 19

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2019 Portfolio in Review

As of Q3 2019, Candriam SCA held 863 positions worth $7.55B, down 5.9% from $8.02B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA withdrew a net $301M in Q3 2019, closing 128 positions and reducing 256 holdings. Its most notable exit was Celgene Corp, an estimated $70.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in Nike worth $27.8M.

  • Candriam SCA's largest Q3 2019 buy was Nike: 295,763 shares worth $27.8M.
  • Candriam SCA added most to AbbVie in Q3 2019, an estimated $21.9M increase.
  • Candriam SCA's biggest Q3 2019 reduction was Biogen, cutting an estimated $43.3M.
  • Candriam SCA fully exited Celgene Corp in Q3 2019, selling an estimated $70.2M.
  • Candriam SCA's ten largest holdings make up 21% of its $7.55B portfolio in Q3 2019.
  • Candriam SCA opened 59 new positions and closed 128 in Q3 2019.
  • Candriam SCA's portfolio value fell 5.9% quarter-over-quarter to $7.55B.

Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.